As expected, the enriched KEGG pathways have been shown to be highly and significantly involved in transcriptional misregulation in cancer, suggesting that transcriptional modulation stimulating invasion and metastasis might be involved in the aggressive performance of CD133+ liver CSCs (Figure 1D). This evidence concerns the gene PROM1 and cancer.